Polycarboxylic Acid Patents (Class 560/44)
  • Patent number: 11897830
    Abstract: An amorphous form of dezocine analogue hydrochloride is represented by formula (II). An X-ray powder diffraction spectrum of the amorphous form is shown in FIG. 1.
    Type: Grant
    Filed: May 6, 2022
    Date of Patent: February 13, 2024
    Assignee: SHANDONG DANHONG PHARMACEUTICAL CO., LTD.
    Inventors: Yang Zhang, Wentao Wu, Zhixiang Li
  • Patent number: 11339119
    Abstract: The present invention relates to a crystal form and an amorphous form of dezocine analogue hydrochloride, and in particularly, to a crystal form of a compound represented by formula (I) and an amorphous form of a compound represented by formula (II). An X-ray powder diffraction spectrum of the crystal form comprises characteristic peaks at 2? values of 13.1°±0.2°, 16.8±0.2°, and 18.5±0.2°, and an X-ray powder diffraction spectrum of the amorphous form is shown in FIG. 1.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: May 24, 2022
    Assignee: SHANDONG DANHONG PHARMACEUTICAL CO., LTD.
    Inventors: Yang Zhang, Wentao Wu, Zhixiang Li
  • Patent number: 9017922
    Abstract: A chemically amplified resist composition comprising a base polymer and an amine quencher in the form of a ?-alanine, ?-aminobutyric acid, 5-aminovaleric acid, 6-aminocaproic acid, 7-aminoheptanoic acid. 8-aminooctanoic acid or 9-aminononanoic acid derivative having an unsubstituted carboxyl group has a high contrast of alkaline dissolution in rate before and after exposure and forms a pattern of good profile at a high resolution, minimal roughness and wide DOF.
    Type: Grant
    Filed: September 10, 2013
    Date of Patent: April 28, 2015
    Assignee: Shin-Etsu Chemical Co., Ltd.
    Inventors: Jun Hatakeyama, Masayoshi Sagehashi
  • Publication number: 20150051407
    Abstract: The present invention relates to a novel process for preparing cis-alkoxy-substituted spirocyclic phenylacetylamino acid esters and cis-alkoxy-substituted spirocyclic 1H-pyrrolidine-2,4-dione derivatives, and also to novel intermediates and starting materials which are produced and/or used in the process according to the invention.
    Type: Application
    Filed: March 25, 2013
    Publication date: February 19, 2015
    Applicant: BAYER INTELLECTUAL PROPERTY GMBH
    Inventors: Taraneh Farida, Berndt Maiwald, Martin Littmann, Winfried Etzel
  • Publication number: 20140363824
    Abstract: The present invention provides fluorogenic compounds for the detection of target metal ions wherein the compounds exhibit a Stokes shift greater than 50 nm and the detectable signal is modulated by photoinduced electron transfer (PET). The present compounds consist of three functional elements, the ion sensing moiety (chelating moiety), the reporter moiety (fluorophore or fluorescent protein) and spacer or linker between the sensing and reporter moieties of the present compound that allows for PET upon binding of a metal ion and excitation by an appropriate wavelength.
    Type: Application
    Filed: June 17, 2014
    Publication date: December 11, 2014
    Inventors: Kyle Gee, Vladimir Martin
  • Patent number: 8900796
    Abstract: The present invention provides an acid generator generates a sulfonic acid represented by the following general formula (1) in response to high-energy beam or heat: To provide a novel acid generator which is suitably used as an acid generator for a resist composition, which solves the problems of LER and a depth of focus and can be effectively and widely used particularly without degradation of a resolution, a chemically amplified resist composition using the same, and a patterning process.
    Type: Grant
    Filed: February 15, 2013
    Date of Patent: December 2, 2014
    Assignee: Shin-Etsu Chemical Co., Ltd.
    Inventors: Masaki Ohashi, Tomohiro Kobayashi, Masayoshi Sagehashi
  • Publication number: 20140309193
    Abstract: There are provided inter alia compounds of formula (I) wherein R1, R2, R3, R4a and R4b are as defined in the specification and their use in therapy, especially in the treatment of bacterial (e.g. pneumococcal) infections.
    Type: Application
    Filed: December 5, 2012
    Publication date: October 16, 2014
    Inventors: Peter William Andrew, Rana Lonnen, Mafalda Pires Damaso, Fritz-Frieder Frickel, Simon Christopher Hirst, Mark William Davies, Daniel Hamza
  • Publication number: 20140107368
    Abstract: A pest control agent containing a compound represented by the following Formula (1), wherein A represents a carbon atom, a nitrogen atom, or the like, K represents a non-metal atom group necessary for forming a cyclic linking group derived from a 5- or 6-membered aromatic ring, in combination with A and two carbon atoms to which A bonds, X represents a hydrogen atom, a halogen atom, or the like, n represents an integer of from 0 to 4, T represents —C(=G1)-Q1 (wherein G1 and G2 represent an oxygen atom or the like, Q1 represents a phenyl group which may have a substituent, a heterocyclic group which may have a substituent, or the like), or the like, Q2 represents a phenyl group or the like, G3 represents an oxygen atom or the like, and R1 and R2 each independently represent a hydrogen atom, a C1-C6 alkyl group, or a group represented by -L-D, or the like (provided that at least either R1 or R2 represents a group represented by -L-D); as an active ingredient exhibits an excellent effect.
    Type: Application
    Filed: December 11, 2013
    Publication date: April 17, 2014
    Applicant: Mitsui Chemicals Agro, Inc.
    Inventors: Yumi Kobayashi, Hiroyuki Katsuta, Michikazu Nomura, Hidetaka Tsukada, Atsushi Hirabayashi, Hidenori Daido, Yusuke Takahashi, Shinichi Banba
  • Patent number: 8680320
    Abstract: The present invention provides a metal chelator and methods that facilitate binding, detecting, monitoring and quantitating of heavy metal ions in a sample.
    Type: Grant
    Filed: December 11, 2009
    Date of Patent: March 25, 2014
    Assignee: Life Technologies Corporation
    Inventors: Kyle Gee, Jolene Bradford, Vladimir Martin
  • Publication number: 20140031368
    Abstract: This disclosure is related to compounds having the structure wherein Ar1, Ar2, R1-R6, Z, m, n, o, and p are defined herein. This disclosure also relates to pharmaceutical compositions comprising the above compounds and methods for their use.
    Type: Application
    Filed: July 8, 2013
    Publication date: January 30, 2014
    Applicants: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH
    Inventors: Ronald Breslow, Paul A. Marks, K. G. Abhilash, Jianing Wang
  • Patent number: 8633228
    Abstract: A pest control agent containing a compound represented by the following Formula (1), wherein A represents a carbon atom, a nitrogen atom, or the like, K represents a non-metal atom group necessary for forming a cyclic linking group derived from a 5- or 6-membered aromatic ring, in combination with A and two carbon atoms to which A bonds, X represents a hydrogen atom, a halogen atom, or the like, n represents an integer of from 0 to 4, T represents —C(?G1)-Q1 (wherein G1 and G2 represent an oxygen atom or the like, Q1 represents a phenyl group which may have a substituent, a heterocyclic group which may have a substituent, or the like), or the like, Q2 represents a phenyl group or the like, G3 represents an oxygen atom or the like, and R1 and R2 each independently represent a hydrogen atom, a C1-C6 alkyl group, or a group represented by -L-D, or the like (provided that at least either R1 or R2 represents a group represented by -L-D); as an active ingredient exhibits an excellent effect.
    Type: Grant
    Filed: June 29, 2009
    Date of Patent: January 21, 2014
    Assignee: Mitsui Chemicals Agro, Inc.
    Inventors: Yumi Kobayashi, Hiroyuki Katsuta, Michikazu Nomura, Hidetaka Tsukada, Atsushi Hirabayashi, Hidenori Daido, Yusuke Takahashi, Shinichi Banba
  • Patent number: 8569535
    Abstract: The present invention relates to novel compounds of the formula Ia: in any of its stereoisomeric forms or a mixture of stereoisomeric forms in any ratio, or a physiologically acceptable salt thereof, wherein the substituents are as described herein. The inventive compounds have CXCR5 inhibitory activity, and are particularly useful in treating or preventing various inflammatory diseases, such as rheumatoid arthritis, multiple sclerosis, lupus, Crohn's Disease, associated with the modulation of the human CXCR5 receptor.
    Type: Grant
    Filed: November 30, 2009
    Date of Patent: October 29, 2013
    Assignee: Sanofi
    Inventors: Thomas Joseph Caulfield, Jennifer Williford Clemens, Robert S. Francis, Brian Scott Freed, Stanly John, Tieu-Binh Le, Brian Pedgrift, Antonio Daniel Ramos, Gerard Charles Rosse, Martin Smrcina, David Squire Thorpe, William Shelly Wire, Jianhong Zhao
  • Patent number: 8557922
    Abstract: A diamine compound of formula (I) is proposed as well as polymers, copolymers, polyamic acids, polyamic acid esters, or polyimides based on such compound.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: October 15, 2013
    Assignee: Rolic AG
    Inventors: Thomas Bachels, Zoubair Mohammed Cherkaoui, Guy Marck, Olivier Muller, Joachim Reichardt, Andreas Schuster, Hubert Seiberle, Peggy Studer, Thomas Peglow, Jean-Francois Eckert
  • Patent number: 8507715
    Abstract: An optically active ?-aminocarbonyl compound is obtained by a Mannich reaction between an aldimine in which: nitrogen is protected and a malonic acid diester, in the presence of optically active BINOL and dialkyl magnesium (in which two alkyl groups are the same or different) in an amount 1 to 2 molar times the amount of the BINOL.
    Type: Grant
    Filed: June 22, 2011
    Date of Patent: August 13, 2013
    Assignee: National University Corporation Nagoya University
    Inventors: Kazuaki Ishihara, Manabu Hatano, Takahiro Horibe
  • Patent number: 8466081
    Abstract: Disclosed are halogenated amide esters that are suitable as internal electron donors in procatalyst compositions. Ziegler-Natta catalyst compositions containing the present procatalyst compositions exhibit improved catalyst activity and/or improved catalyst selectivity and produce propylene-based olefins with broad molecular weight distribution.
    Type: Grant
    Filed: February 24, 2011
    Date of Patent: June 18, 2013
    Assignee: Dow Global Technologies LLC
    Inventors: Linfeng Chen, Tak W. Leung, Tao Tao, Kuanqiang Gao, James X. Shu
  • Patent number: 8445291
    Abstract: Provide is a method for detecting a target substance, which method can visualize the expression of the target substance at any time point while reducing influences on the functions of the target substance, can use fluorescent dyes having various excitation/emission wavelengths, and can achieve easy staining process. Also provided are a tag, a DNA, a vector, a probe and a detection kit suitable for use in the above-described detection method. Specifically, the method for detecting a target substance, comprises the steps of bringing into contact with each other (a) a tag comprising a polypeptide forming an ?-helix structure, the tag bound to the target substance, and (b) a probe comprising a compound bound to a fluorescent dye; and measuring the fluorescence emitted by the fluorescent dye. The binding of the tag ?-helix structure to the probe compound induces a spectral change in the fluorescence emitted by the fluorescent dye.
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: May 21, 2013
    Assignee: National University Corporation Tokyo Medical and Dental University
    Inventors: Hirokazu Tamamura, Hiroshi Tsutsumi
  • Patent number: 8420851
    Abstract: The present invention relates to novel compounds of general formula (I) which are thyroid receptor ligands and are preferably selective for the thyroid hormone receptor beta (TR-Beta). Further, the present invention relates to processes of preparing such compounds, their tautomeric forms, novel intermediates involved in their synthesis, their pharmaceutically acceptable salts, methods for using such compounds and pharmaceutical compositions containing them.
    Type: Grant
    Filed: October 15, 2007
    Date of Patent: April 16, 2013
    Assignee: Cadila Healthcare Limited
    Inventors: Saurin Raval, Preeti Raval, Braj Bhushan Lohray, Vidya Bhushan Lohray, Pankaj R. Patel
  • Publication number: 20130079543
    Abstract: An optically active ?-aminocarbonyl compound is obtained by a Mannich reaction between an aldimine in which: nitrogen is protected and a malonic acid diester, in the presence of optically active BINOL and dialkyl magnesium (in which two alkyl groups are the same or different) in an amount 1 to 2 molar times the amount of the BINOL.
    Type: Application
    Filed: June 22, 2011
    Publication date: March 28, 2013
    Applicant: NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY
    Inventors: Kazuaki Ishihara, Manabu Hatano, Takahiro Horibe
  • Publication number: 20130052571
    Abstract: Provided is a compound represented by the following General Formula (I): wherein in General Formula (I), F represents a charge transporting subunit, L represents a linking group having a valency of (n+1) that is formed by combining two or more kinds selected from a group consisting of an alkylene group, —C?C— (an alkenylene group), —C(?O)—, —N(R)—, —O—, and —S—, and R represents a hydrogen atom, an alkyl group, an aryl group, or an aralkyl group, m represents an integer of from 1 to 6, and n represents an integer of from 2 to 3.
    Type: Application
    Filed: February 16, 2012
    Publication date: February 28, 2013
    Applicant: FUJI XEROX CO., LTD.
    Inventors: Wataru YAMADA, Katsumi NUKADA, Yuko IWADATE, Tomoya SASAKI, Kenji KAJIWARA
  • Publication number: 20130012611
    Abstract: Compounds of formula (I): wherein Ar represents an, optionally substituted, aryl or heteroaryl group, R represents an, optionally substituted, aryl or heteroaryl group, an optionally substituted straight or branched chain C1.10-alkyl, R1 is H or methyl, X is an extender group, n is 0 or an integer between 1 and 12 inclusive, A is a polyol residue wherein the unsubstituted polyol from which the residue is derived has at least y OH groups, and y is an integer>1, can easily be prepared, and are useful as synergists in radiation curing.
    Type: Application
    Filed: March 25, 2011
    Publication date: January 10, 2013
    Inventors: Robert Stephen Davidson, Shaun Lawrence Herlihy
  • Publication number: 20130004679
    Abstract: A diamine compound of formula (I) is proposed as well as polymers, copolymers, polyamic acids, polyamic acid esters, or polyimides based on such compound.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 3, 2013
    Applicant: ROLIC AG
    Inventors: Thomas BACHELS, Zoubair Mohammed CHERKAOUI, Guy MARCK, Olivier MULLER, Joachim REICHARDT, Andreas SCHUSTER, Hubert SEIBERLE, Peggy STUDER, Thomas PEGLOW, Jean-Francois ECKERT
  • Publication number: 20130004887
    Abstract: Disclosed herein are novel nitrone compounds, holographic recording media that include the nitrone compound(s) and a polymer binder, a method of manufacturing a holographic recording medium where the nitrone compound, as a photochromic dye, is mixed with a polymer binder to form a holographic composition and molding the holographic composition into holographic data recording medium. Disclosed herein too is a method for recording a hologram by exposing the holographic recording medium to mutually coherent signal and reference light sources at a wavelength that causes a change in the chemical structure of the nitrone compound.
    Type: Application
    Filed: October 20, 2011
    Publication date: January 3, 2013
    Applicant: SABIC INNOVATIVE PLASTICS IP B.V.
    Inventors: Shantaram Narayan Naik, Michael T. Takemori, Sumeet Jain, Pradeep Nadkarni, Mark A. Cheverton, Kiran Arunkumar Puthamane, Vinodkumar Vasudevan, Gary Davis
  • Publication number: 20120316234
    Abstract: The present invention is related to an anthraquinone-based compound represented by compound (I) wherein the R1, R2, R3, R4, R5 or R6 is selected by the group of H, amide, amino-amide, acyl, chloroacetamide, chloropropionamido, a substituted chloroacetamide and a substituted chloropropionamido. The present invention is also related to the method of producing the anthraquinone-based compound and the application thereof.
    Type: Application
    Filed: October 7, 2011
    Publication date: December 13, 2012
    Applicant: NATIONAL DEFENSE MEDICAL CENTER
    Inventor: Hsu-Shan HUANG
  • Patent number: 8329823
    Abstract: A diamine compound of formula (I) is proposed as well as polymers, copolymers, polyamic acids, polyamic acid esters, or polyimides based on such compound.
    Type: Grant
    Filed: December 1, 2011
    Date of Patent: December 11, 2012
    Assignee: ROLIC AG
    Inventors: Thomas Bachels, Zoubair Mohammed Cherkaoui, Guy Marck, Olivier Muller, Joachim Reichardt, Andreas Schuster, Hubert Seiberle, Peggy Studer, Thomas Peglow, Jean-Francois Eckert
  • Publication number: 20120202756
    Abstract: The present invention relates to prodrugs of a wide variety of drugs and pharmaceutical compositions containing such prodrugs. Methods for minimizing locally mediated (from within the gut lumen) adverse gastrointestinal events associated with the underivatised drug and increasing the sustainment of plasma drug levels with the aforementioned prodrugs are also provided. Thus, the present invention relates to the use of prodrugs of a wide diversity of drugs (other than opioids) to transiently inactivate them and so reduce directly, locally mediated adverse gastrointestinal (GI) side-effects normally evident after administration of the parent compound. Additionally, such prodrugs may confer improved pharmacokinetics.
    Type: Application
    Filed: October 5, 2011
    Publication date: August 9, 2012
    Inventors: Richard Franklin, Martin Quibell, Robert G. Tyson, Bernard T. Golding
  • Publication number: 20120197037
    Abstract: The present invention relates to the discovery of new class of linear and multiarmed hydrolysable linkers and cross linkers for use in the synthesis of biodegradable polymers such as, polyesters, polyurethanes, polyamides, polyureas and degradable epoxy amine resin. The linear and multiarmed hydrolysable linkers of the present invention include symmetrical and/or unsymmetrical ether carboxylic acids, amines, amide diols, amine polyols and isocyanates.
    Type: Application
    Filed: September 23, 2011
    Publication date: August 2, 2012
    Applicant: BEZWADA BIOMEDICAL, LLC
    Inventor: Rao S. Bezwada
  • Publication number: 20120141938
    Abstract: A chemically amplified resist composition comprising a base polymer, an acid generator, and an amine quencher in the form of a ?-alanine, ?-aminobutyric acid or 5-aminovaleric acid derivative having an acid labile group-substituted carboxyl group has a high contrast of alkaline dissolution rate before and after exposure and forms a pattern of good profile at a high resolution, minimal roughness and wide focus margin.
    Type: Application
    Filed: December 5, 2011
    Publication date: June 7, 2012
    Applicant: SHIN-ETSU CHEMICAL CO., LTD.
    Inventors: Jun Hatakeyama, Masayoshi Sagehashi, Takeru Watanabe
  • Patent number: 8173749
    Abstract: A diamine compound of formula (I) is proposed as well as polymers, copolymers, polyamic acids, polyamic acid esters, or polyimides based on such compound.
    Type: Grant
    Filed: December 19, 2006
    Date of Patent: May 8, 2012
    Assignee: Rolic AG
    Inventors: Thomas Bachels, Zoubair Mohammed Cherkaoui, Guy Marck, Olivier Muller, Joachim Reichardt, Andreas Schuster, Hubert Seiberle, Peggy Studer, Thomas Peglow, Jean-Francois Eckert
  • Publication number: 20120088888
    Abstract: To provide a novel polyimide precursor or polyimide which can provide a liquid crystal alignment film having a low volume resistivity, a liquid crystal aligning agent containing these polymers, a liquid crystal alignment film and a novel diamine which is useful as the starting material of these polymers.
    Type: Application
    Filed: March 9, 2010
    Publication date: April 12, 2012
    Applicant: Nissan Chemical Industries, Ltd.
    Inventor: Masato Nagao
  • Publication number: 20120076952
    Abstract: A diamine compound of formula (I) is proposed as well as polymers, copolymers, polyamic acids, polyamic acid esters, or polyimides based on such compound.
    Type: Application
    Filed: December 1, 2011
    Publication date: March 29, 2012
    Applicant: ROLIC AG
    Inventors: Thomas BACHELS, Zoubair Mohammed CHERKAOUI, Guy MARCK, Olivier MULLER, Joachim REICHARDT, Andreas SCHUSTER, Hubert SEIBERLE, Peggy STUDER, Thomas PEGLOW, Jean-François ECKERT
  • Publication number: 20120009683
    Abstract: The present invention provides fluorogenic compounds for the detection of target metal ions wherein the compounds exhibit a Stokes shift greater than 50 nm and the detectable signal is modulated by photoinduced electron transfer (PET). The present compounds consist of three functional elements, the ion sensing moiety (chelating moiety), the reporter moiety (fluorophore or fluorescent protein) and spacer or linker between the sensing and reporter moieties of the present compound that allows for PET upon binding of a metal ion and excitation by an appropriate wavelength.
    Type: Application
    Filed: July 29, 2011
    Publication date: January 12, 2012
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: Kyle Richard GEE, Vladimir MARTIN
  • Publication number: 20110269967
    Abstract: Novel amic acids and amic esters can be thermally converted into corresponding arylene diimides. These amic acids and amic ester can be used as precursors to prepare semiconducting thin films that can be used in various articles including thin-film transistor devices that can be incorporated into a variety of electronic devices. In this manner, the arylene diimides need not be coated out of solvent in which they may be insoluble, but they can be generated in situ from a solvent-soluble, easily coated amic acid or amic ester.
    Type: Application
    Filed: April 30, 2010
    Publication date: November 3, 2011
    Inventors: Deepak Shukla, Dianne M. Meyer, Wendy G. Ahearn
  • Patent number: 8039663
    Abstract: The invention is based on the discovery that certain well-defined compounds derived from pentacyclopentadecane dimethanol are useful components in adhesive formulations. In particular, the invention compounds described herein provide high Tg values and low shrinkage. Compounds of the invention are useful as adhesives for use in the semiconductor packaging industry.
    Type: Grant
    Filed: April 9, 2008
    Date of Patent: October 18, 2011
    Assignee: Designer Molecules, Inc.
    Inventor: Stephen M. Dershem
  • Publication number: 20110152290
    Abstract: The present invention relates to compounds of the formula I, wherein A, Y, Z, R3 to R6, R20 to R22 and R50 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. Specifically, they are inhibitors of the endothelial differentiation gene receptor 2 (Edg-2, EDG2), which is activated by lysophosphatidic acid (LPA) and is also termed as LPA1 receptor, and are useful for the treatment of diseases such as atherosclerosis, myocardial infarction and heart failure, for example. The invention furthermore relates to processes for the preparation of the compounds of the formula I, their use and pharmaceutical compositions comprising them.
    Type: Application
    Filed: November 4, 2010
    Publication date: June 23, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Matthias SCHAEFER, Josef PERNERSTORFER, Dieter KADEREIT, Hartmut STROBEL, Werngard CZECHTIZKY, L. Charlie CHEN, Alena SAFAROVA, Aleksandra WEICHSEL, Marcel PATEK
  • Publication number: 20110136878
    Abstract: A pest control agent containing a compound represented by the following Formula (1), wherein A represents a carbon atom, a nitrogen atom, or the like, K represents a non-metal atom group necessary for forming a cyclic linking group derived from a 5- or 6-membered aromatic ring, in combination with A and two carbon atoms to which A bonds, X represents a hydrogen atom, a halogen atom, or the like, n represents an integer of from 0 to 4, T represents —C(=G1)-Q1 (wherein G1 and G2 represent an oxygen atom or the like, Q1 represents a phenyl group which may have a substituent, a heterocyclic group which may have a substituent, or the like), or the like, Q2 represents a phenyl group or the like, G3 represents an oxygen atom or the like, and R1 and R2 each independently represent a hydrogen atom, a C1-C6 alkyl group, or a group represented by -L-D, or the like (provided that at least either R1 or R2 represents a group represented by -L-D); as an active ingredient exhibits an excellent effect.
    Type: Application
    Filed: June 29, 2009
    Publication date: June 9, 2011
    Applicant: Mitsui Chemicals Agro., Inc.
    Inventors: Yumi Kobayashi, Hiroyuki Katsuta, Michikazu Nomura, Hidetaka Tsukada, Atsushi Hirabayashi, Hidenori Daido, Yusuke Takahashi, Shinichi Banba
  • Publication number: 20110086073
    Abstract: The present invention describes nanoprodrugs of non-steroidal anti-inflammatory drug (NSAIDs) and nanoprodrugs of ?-lipoic acid-containing and NSAIDs. These nanoprodrugs have antioxidant properties and stimuli-responsiveness, which can be used to treat various disease conditions.
    Type: Application
    Filed: April 8, 2009
    Publication date: April 14, 2011
    Applicant: Cedars-Sinai Medical Center
    Inventors: John S. Yu, Bong Seop Lee
  • Publication number: 20110065859
    Abstract: A thermally stable diamine compound of formula (I?) is proposed as well as polymers, copolymers, polyamic acids, polyamic acid esters, or polyimides based on such compound.
    Type: Application
    Filed: April 10, 2008
    Publication date: March 17, 2011
    Applicant: ROLIC AG
    Inventors: Izabela Bury, Guy Marck, Satish Palika, Peggy Studer
  • Patent number: 7888532
    Abstract: A two-photon probe for real-time monitoring of intracellular magnesium ions is provided. Specifically, the two-photon probe is represented by Formula 1: wherein R is H or CH2OCOCH3. The two-photon probe is very suitable for real-time imaging of intracellular magnesium ions. The two-photon probe shows 17-fold two-photon excited fluorescence enhancement in response to Mg2+, which is 7-fold stronger than commercial probes, thus enabling staining of cells in a greatly reduced amount. In addition, the two-photon probe has a sufficiently low molecular weight to stain cells and is very suitable for monitoring Mg2+ ions present in the deep tissue. Furthermore, the two-photon probe can be effectively used for the quantitative as well as qualitative detection of intracellular magnesium ions. Further provided are a method for preparing the two-photon probe and a method for real-time monitoring of intracellular magnesium ions using the two-photon probe.
    Type: Grant
    Filed: December 14, 2007
    Date of Patent: February 15, 2011
    Assignee: Korea University Industry and Academy Cooperation Foundation
    Inventor: Bong-Rae Cho
  • Publication number: 20110004003
    Abstract: A novel high-performance material is provided. A certain aspect of the present invention lies in a 2,3-bis(N,N-bis(p-anisyl)4-aminophenylethynyl)dimethylfumarate producing method, characterized by illuminating light onto 2,3-bis(N,N-bis(p-anisyl)4-aminophenylethynyl)dimethylmaleate. Also, a further certain aspect of the present invention lies in a 2,3-bis(N,N-bis(p-anisyl)4-aminophenylethynyl)dimethylmaleate producing method, characterized by illuminating light onto 2,3-bis(N,N-bis(p-anisyl)4-aminophenylethynyl)dimethylfumarate. According to this constitution, there can be obtained a high-performance material by a simple technique.
    Type: Application
    Filed: August 1, 2008
    Publication date: January 6, 2011
    Applicant: The University of Tokyo
    Inventors: Hiroshi Nishihara, Ryota Sakamoto
  • Publication number: 20100286008
    Abstract: An additive for oils that is capable of imparting oils such as lubricant base oils or fuel oils with superior wear resistance properties or superior friction resistance properties and the like are provided. The additive for oils comprising a compound represented by formula (I): [Chemical Formula 1] (A)m-W—(B)n ??(I) wherein m represents an integer of 0 to 4, n represents an integer of 2 to 6, A represents hydroxy or amino, W represents hydrocarbon or the like, and B represents formula (II): wherein a represents 0 or 1, X represents an oxygen atom or NH, Y represents OR1 or NHR2 (wherein R1 and R2 each represent alkyl optionally having one or more substituents or the like), and Z1 and Z2 each represent a hydrogen atom, NR3R4 (wherein R3 and R4 each represent alkyl optionally having one or more substituents or the like) or the like, and the like are provided.
    Type: Application
    Filed: May 9, 2008
    Publication date: November 11, 2010
    Applicant: KYOWA HAKKO CHEMICAL CO., LTD.
    Inventors: Satoshi Hiyoshi, Junya Kishi, Shingo Nakayama, Suguru Ohara, Yukihiro Isogai
  • Publication number: 20100280268
    Abstract: The present invention concerns a fluorescence resonance energy transfer based high throughput test system to measure the formation of the HIV gp41 six-helix bundle. In a first embodiment the current invention relates to a homogeneous time resolved fluorescence-based test system comprising a first helical polypeptide consisting essentially of the sequence of IQN36 (SEQ ID NO:1); a second helical polypeptide consisting essentially of the sequence of C34 (SEQ ID NO: 2) wherein said IQN36 is labeled with a light emitting fluorophore and said C34 is labeled with an ultra-violet excitable fluorophore.
    Type: Application
    Filed: April 6, 2007
    Publication date: November 4, 2010
    Inventors: Géry Karel Julia Dams, Inge Vereycken, Koenraad Lodewijk August Van Acker, Emmanuel Marie Paul Ernest Gustin, Wim Gaston Verschueren, Asa Catrine Ohagen
  • Patent number: 7759452
    Abstract: A functional aspartate prepared by A) reacting an aziridine with a Michael-acceptor molecule to form an aziridinyl aspartate, and B) reacting the aziridinyl aspartate with an active hydrogen containing compound to form the functional aspartate. The functional aspartate can be used in adhesive, sealant or coating compositions that also include an isocyanate functional material. The composition can be used in a method of bonding a first substrate to a second substrate that includes applying a coating of the above-identified adhesive composition to at least one surface of the first substrate or the second substrate, and contacting a surface of the first substrate with a surface of the second substrate, where at least on of the contacting surfaces has the coating applied thereto. The composition can also be used to coat substrates.
    Type: Grant
    Filed: January 15, 2009
    Date of Patent: July 20, 2010
    Assignee: Bayer MaterialScience LLC
    Inventors: Karsten Danielmeier, Douglas A. Wicks, Karen Marie Henderson, Evan Randall Minnich, John J. McLafferty, Stephanie A. Strazisar, Kurt C. Frisch, Jr.
  • Publication number: 20100144977
    Abstract: A variety of curing agents for epoxy resins and methods for preparation thereof are disclosed, including compounds having the structures of formulas III and IV: wherein each of R1, R2, R3, R4, and R5 is independently selected from the group consisting of H, methyl, ethyl, n-propyl, iso-propyl, a butyl, and phenyl. Epoxy-based compositions including various curing agents are also disclosed. Other epoxy curatives containing amino, phenol, and/or imine groups are disclosed.
    Type: Application
    Filed: November 20, 2009
    Publication date: June 10, 2010
    Applicant: DESIGNER MOLECULES, INC.
    Inventor: Stephen M. Dershem
  • Publication number: 20100130393
    Abstract: Reaction of a carboxylic acid-containing polymer with certain aromatic amines and polyols results in ester containing dispersant viscosity modifiers with improved soot handling performance in heavy-duty diesel engines, compared with non-ester containing dispersants.
    Type: Application
    Filed: January 4, 2008
    Publication date: May 27, 2010
    Applicant: The Lubrizol Corporation
    Inventors: Matthew D. Gieselman, John K. Pudelski, Renee A. Eveland, Adam J. Preston
  • Publication number: 20100041665
    Abstract: The present invention is related to a family of N-phenyl-prenylamine derivatives of formula (I), and to their use in the treatment of cognitive, neurodegenerative or neuronal diseases or disorders, such as Alzheimer's disease or Parkinson's Disease. The present invention also relates to pharmaceutical compositions comprising the same. Further, the present invention is directed to the use of the compounds in the manufacture of a medicament for the treatment and/or prevention of a cognitive, neurodegenerative or neuronal disease or disorder.
    Type: Application
    Filed: August 1, 2007
    Publication date: February 18, 2010
    Applicant: NOSCIRA, S.A.
    Inventors: Ana Martinez Gil, Ana Castro Morera, Miguel Medina Padilla, Pilar Munoz Ruiz, Javier Lopez Ogalla, Esther Garcia Palomero, Celia De Austria De Luque, Paola Usan Egea, Rita Valenzuela Liminana, Pablo Garcia Fernandez, Elena Delgado Hernandez, Daniel Ignacio Perez Fernandez
  • Publication number: 20090231663
    Abstract: An electrochromic compound having in the molecule at least an adsorbable group, a redox chromophore and a spacer portion, and represented by the following General Formula (1): wherein A represents the adsorbable group, C represents the redox chromophore, and X represents the spacer portion represented by the following formula; wherein R1 and R3 each represent an aliphatic hydrocarbon group or an aromatic derivative group, R2 represents a hydrogen atom or a monovalent group.
    Type: Application
    Filed: March 10, 2009
    Publication date: September 17, 2009
    Inventors: Shigenobu HIRANO, Takeshi Shibuya, Hiroshi Kondo, Yuki Nakamura, Yukiko Abe, Tohru Yashiro
  • Publication number: 20090105352
    Abstract: This invention relates to the discovery of functionalized triclosan monomers and oligomers that, when incorporated into a substrate of, or applied as part of a coating to, medical devices and/or consumer products may extend the duration of antimicrobial properties to the medical devices and/or consumer products.
    Type: Application
    Filed: September 17, 2008
    Publication date: April 23, 2009
    Applicant: Bezwada Biomedical, LLC
    Inventor: Rao S. Bezwada
  • Patent number: 7521577
    Abstract: The present invention provides a metal chelator and methods that facilitate binding, detecting, monitoring and quantitating of heavy metal ions in a sample.
    Type: Grant
    Filed: January 12, 2007
    Date of Patent: April 21, 2009
    Assignee: Molecular Probes, Inc.
    Inventors: Kyle R. Gee, Jolene Bradford, Vladimir V. Martin
  • Publication number: 20090085008
    Abstract: A cellulose compound composition, containing at least one compound of formula (1): wherein R1 to R5 are a hydrogen atom or a substituent, and any one of R1 to R5 is -L3-Q1, in which Q1 is a group of formula Q1: in which * is a bonding hand for bonding with L3, R is a hydrogen atom or an alkyl group, m and r are an integer of 0 or more, R6 is a hydrogen atom or a substituent; L1, L2 and L3 are a single bond or a divalent linking group, Ar1 is an arylene or aromatic heterocyclic group, Ar2 represents an aryl or aromatic heterocyclic group, and n is an integer of 0 or more, in which two or more L2s and two or more Ar1s each may be the same or different from each other; and a film composed of the composition.
    Type: Application
    Filed: October 24, 2006
    Publication date: April 2, 2009
    Applicant: FUJIFILM Corporation
    Inventors: Satoshi Tanaka, Shigeki Uehira, Nobutaka Fukagawa
  • Patent number: 7485742
    Abstract: A new class of non-glycosidic and non-peptidic inhibitors of selectins with low molecular weight according to the general formula 1 is described, as well as methods for their production. These compounds represent a new class of non-toxic, in vivo anti-inflammatory effective inhibitors of selectins, and do not exhibit the disadvantages of the glycosidic inhibitor complexes, and are furthermore more potent in vitro, compared to the known drug bimosiamose. Furthermore, medicaments containing the compounds and their uses in the treatment of diseases are described.
    Type: Grant
    Filed: July 26, 2005
    Date of Patent: February 3, 2009
    Assignee: Johannes Gutenberg-Universität Mainz
    Inventors: Gerd Dannhardt, Holger Ulbrich, Philip Prech, Andreas Luxenburger